• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
Research on related companies


Related Content

View the latest research on other companies in the sector. 

Q3 profitability beat was sizeable; resilient operations

Reversing paper and related market excesses of 2021-22 remains an unchanged reality, which was also evident in Holmen’s Q3 results. Profitability (despite some moderation) nonetheless smashed the street’s expectations. Forest continued to be a solid support and was well-complemented by Paper plus Energy. While there were sustained challenges in Paperboard and Wood, these are not lasting concerns. Overall, with better preservation of profitability in challenging markets and growth being well-aligned with customer needs, Holmen remains an attractive and somewhat defensive sector bet.

Holmen Ab-B Shares

  • 27 Oct 23
  • -
  • AlphaValue
Sizeable consensus profitability beat, despite the weak Q2

Like its peers, Holmen reported weak Q2 results. Profitability was however well ahead of the street’s expectations. Valuable support came from Forest, which had been expected, but the bigger surprise came from Paper, which remained extremely-healthy. Although business challenges are likely to persist for the next couple of quarters, Holmen by virtue of its focus areas remains an attractive sector bet and, hence, could be the first to recover (vs. most peers) in terms of both operations and the share price dynamic.

Holmen Ab-B Shares

  • 17 Aug 23
  • -
  • AlphaValue
Q1 23 results smash the street's expectations

While Holmen also witnessed a Q1 performance normalisation, unlike its peers (ex. SCA) its results materially-exceeded the street’s expectations. Barring Wood Products, there were positive takeaways from all the other divisions (despite their performance erosion (risks)). Overall, given the Q1 surprise and the sell-off in recent months, we believe that the upside on Holmen is worth capitalising on. Also, it remains our preferred bet vs. SCA.

Holmen Ab-B Shares

  • 03 May 23
  • -
  • AlphaValue
Impressive Q4 and full-year + another forest revaluation, but caution maintained

2022 ended on an impressive note – with another quarterly beat. While the wood markets’ reversal of fortunes and Paperboard’s maintenance shutdown were some bottlenecks, sizeable tailwinds in other areas pushed the full-year results to record-highs, facilitated further leveraging and, hence, resulted in even higher rewards. Even though we remain wary of another round of forest revaluation gains and, in general, expected medium-term margin normalisation, one can re-consider the firm’s investment once we are past the peak of the interest rate cycle.

Holmen Ab-B Shares

  • 01 Feb 23
  • -
  • AlphaValue
Strong Q3; though stark moderation in Wood was evident

In Q3, while Paperboard, Energy and Forest continued to do well, euphoria is Paper was (again) at an extreme – especially on the back of very-tight markets. However, a sharp reversal of fortunes in Wood was evident. Moreover, with brewing (weather-induced) limitations/risks for Energy and material forest revaluation gains too most-likely nearing an end, sell-off in recent months wasn’t surprising. While there’s a window of opportunity – considering the firm’s ‘relatively’ favourable business mix – a better entry point is still probable.

Holmen Ab-B Shares

  • 14 Nov 22
  • -
  • AlphaValue
Exceptional Q2, led by massive Paper outperformance

On the back of sizeable and broad-based price tailwinds, Holmen reported impressive Q2 results – with profitability materially-ahead of street expectations. While the good performance in stronghold divisions was largely expected, the massive uptick in Paper came as a big surprise. Nevertheless, given the high/growing vulnerability of the current market dynamics for the firm’s most profitable divisions – already evident to some extent in wood – our cautious stock recommendation should be maintained. Any material sell-off could however open-up an entry/accumulation opportunity.

Holmen Ab-B Shares

  • 22 Aug 22
  • -
  • AlphaValue
Record Q1 operating results, but caution is warranted

2022 began on an impressive note, with Holmen reporting ‘record’ quarterly results. The biggest surprise was the turnaround in Paper, and healthy support emanating from Wood and Energy. However, the performance in Forest and Paperboard (traditional strongholds) was somewhat disappointing. While the prospect of various pricing excesses reversing in the coming quarters still remains high, GDP growth and inflation risks (in Europe) are added concerns and hence, our cautious stock recommendation is reiterated.

Holmen Ab-B Shares

  • 29 Apr 22
  • -
  • AlphaValue
Strong results; somewhat better-positioned to withstand risk of reversing market euphoria

Even Holmen reported healthy results on the back of forest and wood market (valuation) euphoria, and buzzing energy markets. These improvements materialised despite below-par packaging results. While we expect forest and wood market tailwinds to reverse – somewhat also evident in the Q4 sector results, Holmen remains well-positioned to limit EPS erosion via promising dynamics in other divisions, and ‘somewhat’ lower downside risk for forest and wood divisions. Also, given the revaluation gains, our DCF and NAV estimates should reset higher.

Holmen Ab-B Shares

  • 01 Feb 22
  • -
  • AlphaValue
Strong Q3; well-positioned to withstand ‘wood + forest’ normalisation

On the back of ‘record’ results in Wood Products and resilience in Forest, Holmen reported strong Q3 results. While these natural resources-centric divisions are set for normalisation in the medium term, the firm is well-positioned to leverage favourable dynamics in other areas, i.e. Paperboard, Paper and Energy. Overall, as we expect group-level margin normalisation to be controlled, profitability/cash flow resilience and, hence, balance sheet flexibility should be maintained, thereby still supporting the case for occasional extraordinary shareholder rewards.

Holmen Ab-B Shares

  • 26 Oct 21
  • -
  • AlphaValue
Wood-driven Q2 resilience

Strong Q2 results were a function of wood market euphoria. The wood-related gains were such that (temporary) headwinds in forest and paperboard were completely overshadowed. While the prospect of a normalising forest and wood performance is on the rise, Holmen has ample cushion from other divisions to sustain earnings growth. Even after the ytd share price run-up, the stock remains attractive, but with limited upside potential.

Holmen Ab-B Shares

  • 23 Aug 21
  • -
  • AlphaValue
Record Q1 operating results

2021 began on an extraordinary note for Holmen. Q1 results were driven by healthy gains / stability across key / high-margin divisions, which helped dwarf the weakness in Paper. With intact business fundamentals, the current momentum should gradually reflect in better margins and, hence, cash generation capabilities. Our positive recommendation should be maintained.

Holmen Ab-B Shares

  • 10 May 21
  • -
  • AlphaValue
Performance resilience translated into dividend extravagance

Despite a challenging macro environment, Holmen reported healthy Q4 and FY results. As expected, high-margin Forest and Paperboard divisions continued to do well, with apt (surprising) support being rendered by other divisions (ex. Paper). With sorted business fundamentals and, hence, varying growth investments across divisions, Holmen remains in a sweet spot, wherein the sustainability-quotient of its offerings are well-aligned with the markets’ dash for greener stories. This business optimism is also reflected in the group’s 2020 dividend generosity.

Holmen Ab-B Shares

  • 09 Feb 21
  • -
  • AlphaValue
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In